not if they read this link..
https://www.fiercebiotech.com/biotech/gsk-german-merck-s-4-2b-bintrafusp-alfa-drug-a-bust-fails-to-beat-king-keytruda-lung-cancer
pretty much tells everyone that the big pharmas are deciding that keytruda is the winner so lets divert the funds elsewhere... more than likely in another combination therapy with immutep... amazing how Marc has gotten Immutep on all yhe Big Pharmas dance card...
older link for the young punters that have not been following the progression of the competing trials...
https://biotechdispatch.com.au/news/immutep-updates-on-trial-with-msds-keytruda
old news to most here, though it may persuade some to Ho;d their stock...
not if they read this...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |